thecardiologyadvisor.com18h
Risk for Venous Thromboembolism Is Reduced by COVID-19 Vaccination
The risk for VTE was reduced among Military Health Systems beneficiaries who were vaccinated vs unvaccinated against COVID-19.
KNSI Radio2d
Man Whose Murder Conviction Was Overturned Back in Court for New Evidentiary Hearings
(KNSI) - An Albany man whose murder conviction was overturned will be back in a Stearns County courtroom Tuesday as ...
Hosted on MSN20h
Global heparin market to grow by $3.34b by 2028
Key developments include fractionated and low-molecular-weight heparin for thrombosis management. The global heparin market ...
Stoneham Independent2d
GLP-1 Meds May Lower Clot Risk in People With Diabetes
TUESDAY, Dec. 10, 2024 (HealthDay News) -- People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be ...
Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Coagulation Disorder Prevalence and AI Impacting Market Trends - Technavio
Report on how AI is redefining market landscape - The global heparin market size is estimated to grow by USD 3.34 billion from 2024-2028, according to Technavio. The market is estimated to grow at a ...
TCTMD8d
CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy
Venous thromboembolism is a risk with several contemporary HRT formulations, consistent with earlier data. Several ...
Oncology Nurse Advisor6d
Thrombosis Linked With Second Cancer Risk in MPNs
Researchers assessed the link between arterial thrombosis incidence and the risk of developing second cancers in patients with MPNs.
Yahoo Finance3d
Venous Stents Market to Reach US$ 2.4 Billion by 2034, Growing at a 7.2% CAGR | Transparency Market Research, Inc.
Venous stents are primarily used to treat conditions such as chronic deep vein thrombosis (DVT), post-thrombotic syndrome, May-Thurner syndrome, Nutcracker syndrome, and for patients receiving ...